Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.77 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.77 |
| ▸ | RELA | Q04206 | 1/20 | 0.77 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.73 |
| ▸ | PPARG | P37231 | 5/20 | 0.73 |
| ▸ | F7 | P08709 | 4/20 | 0.73 |
| ▸ | F3 | P13726 | 4/20 | 0.73 |
| ▸ | PPARD | Q03181 | 4/20 | 0.73 |
| ▸ | PPARA | Q07869 | 4/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.73 |
| ▸ | ESR1 | P03372 | 1/20 | 0.73 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.73 |
| ▸ | CASP6 | P55212 | 1/20 | 0.73 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6703852 | 1.00 | NFKB1 (0.77) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL6703858 | 1.00 | NFKB1 (0.77) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL18258540 | 0.99 | NFKB1 (0.75) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL27968801 | 0.99 | NFKB1 (0.75) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL31187215 | 0.95 | NFKB1 (0.79) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL18258515 | 0.95 | NFKB1 (0.79) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL7554172 | 0.94 | NFKB1 (0.77) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL31187222 | 0.94 | NFKB1 (0.77) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL18258564 | 0.94 | NFKB1 (0.77) | NFKB1NFKB2RELAFFAR1PPARG | |
| SCHEMBL7551354 | 0.94 | NFKB1 (0.77) | NFKB1NFKB2RELAFFAR1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3677686-B1 | HYDROXYLATED FATTY ACID MULTIMERS AND PRODUCTION METHOD THEREOF | UNIV KYOTO (JP) | 2023-06-07 | — | — | EP | claimed |
| US-11130974-B2 | Hydroxylated fatty acid homopolymer and production method thereof | KYOTO UNIVERSITY (JP) | 2021-09-28 | — | — | US | claimed |
| US-20210236448-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2021-08-05 | — | — | US | claimed |
| US-20210079432-A1 | HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF | KYOTO UNIVERSITY (JP) | 2021-03-18 | — | — | US | claimed |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2021-03-11 | — | — | US | claimed |
| EP-3677686-A1 | HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF | Kyoto University (JP) | 2020-07-08 | — | — | EP | claimed |
| EP-3097910-B1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | UNIV KYOTO (JP) | 2020-05-13 | — | — | EP | claimed |
| US-20200101036-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2020-04-02 | — | — | US | claimed |
| US-20170007564-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-01-12 | — | — | US | claimed |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-01-05 | — | — | US | claimed |
| EP-3097910-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | claimed |
| EP-3097911-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | claimed |
| EP-3097911-B1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | UNIV KYOTO (JP) | 2024-05-22 | — | — | EP | disclosed |
| EP-3677686-B1 | HYDROXYLATED FATTY ACID MULTIMERS AND PRODUCTION METHOD THEREOF | UNIV KYOTO (JP) | 2023-06-07 | — | — | EP | disclosed |
| EP-3098313-B1 | METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID | UNIV KYOTO (JP) | 2022-01-05 | — | — | EP | disclosed |
| US-11130974-B2 | Hydroxylated fatty acid homopolymer and production method thereof | KYOTO UNIVERSITY (JP) | 2021-09-28 | — | — | US | disclosed |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | KYOTO UNIVERSITY (JP) | 2017-01-05 | — | — | US | disclosed |
| EP-3097911-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | disclosed |
| EP-3098313-A1 | METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | disclosed |
| EP-3097910-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | Kyoto University (JP) | 2016-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200101036-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | FASN, ELOVL1, FADS1 | NFKB1 3890/4885NFKB2 4168/4885RELA 4288/4885 |
| US-20170007564-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | ELOVL1, FASN, FADS1 | NFKB1 3616/4885NFKB2 3973/4885RELA 4275/4885 |
| US-20210236448-A1 | METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID | FASN, ELOVL1, FADS1 | NFKB1 3890/4885NFKB2 4168/4885RELA 4288/4885 |
| US-20210079432-A1 | HYDROXYLATED FATTY ACID HOMOPOLYMER AND PRODUCTION METHOD THEREOF | FASN, SCD, SCD5 | NFKB1 2407/4885NFKB2 2511/4885RELA 2107/4885 |
| US-20210069141-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | NFKB1 167/4885NFKB2 245/4885RELA 203/4885 |
| US-20170000752-A1 | ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID | ELOVL1, ELOVL5, ELOVL3 | NFKB1 167/4885NFKB2 245/4885RELA 203/4885 |
| US-11130974-B2 | Hydroxylated fatty acid homopolymer and production method thereof | FASN, SCD, SCD5 | NFKB1 2407/4885NFKB2 2511/4885RELA 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.